Skip to content
Altius – Lifestyle
Author:
Gain Therapeutics, Inc.
Gain Therapeutics Presents Additional Clinical and Biomarker Data from Phase 1b Clinical Study of GT-02287 and Preclinical Data from Novel Chemical Series at AD/PD 2026
March 18, 2026
Gain Therapeutics Announces Presentations at AD/PDTM 2026 and Provides U.S. FDA Regulatory Update
March 12, 2026
←
Previous Page
1
2